CVSI
CV Sciences, Inc.Company Information
- Company Name
- CV Sciences, Inc.
- CIK
- CIK0001510964
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CVSI: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CVSI
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-07
- Last sale
- —
- Shares purchased (TTM)
- 94,854
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2024-09-30
- Institutional shares owned
- 5,100
- Shares outstanding
- 182,261,000
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -33.33%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 2 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | ||||||
| Inventory Net | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Assets Current | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 8 | 9 | 10 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Accrued Liabilities Current | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Current | 0 | 0 | 1 | 0 | 1 | 1 | 1 | - | - | - | - | - | ||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | 0 | 0 | 0 | 1 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 91 | 90 | 89 | 89 | 89 | 89 | 89 | 88 | 88 | 88 | 87 | 87 | ||||||
| Retained Earnings Accumulated Deficit | -89 | -89 | -88 | -88 | -87 | -87 | -87 | -86 | -86 | -85 | -85 | -84 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | - | ||||||
| Stockholders Equity | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | ||||||
| Liabilities And Stockholders Equity | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 8 | 9 | 10 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 790 | 790 | 790 | 790 | 790 | 790 | 790 | 790 | 790 | 790 | 790 | 790 | ||||||
| Common Stock Shares Issued | 213 | 193 | 184 | 184 | 184 | 184 | 184 | 184 | 181 | 163 | 162 | 155 | ||||||
| Shares Outstanding | 213 | 193 | 184 | 184 | 184 | 184 | 184 | 184 | 181 | 163 | 162 | 155 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCV Sciences, Inc. (CVSI) — SEC Financial Statements & Analysis
CV Sciences, Inc. (CVSI) is a pharmaceutical preparations company, incorporated in DE. CV Sciences, Inc. trades on OTC as: CVSI. CV Sciences, Inc. (CVSI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, CV Sciences, Inc. carries a market cap of $4.10M, a P/E ratio of -2.04x, a P/B ratio of 2.61x, a P/S ratio of 0.32x, an enterprise value of $3.85M, and an EV/EBITDA multiple of -4.42x. On profitability, it posts a gross margin of 49.14%, an operating margin of -7.60%, a net margin of -15.74%, a Return on Equity (ROE) of -118.91%, a Return on Assets (ROA) of -27.72%, and a Return on Invested Capital (ROIC) of -48.14%. Per share, it reports EPS of $-0.01, diluted EPS of $-0.01, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -14.90% year-over-year, net income growth of 29.25% year-over-year, and EPS growth of 16.13% year-over-year. On the balance sheet, it maintains a current ratio of 0.99x, a quick ratio of 0.12x, working capital of $-64.00K, a debt-to-equity ratio of 3.15x, a debt ratio of 0.76, an interest coverage ratio of -2.94x, free cash flow of $-522.00K (TTM), and net debt of $-248.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $4.10M
- P/E TTM
- -2.04x
- EPS TTM
- $-0.01
- P/B TTM
- 2.61x
- ROE TTM
- -118.91%
- ROA TTM
- -27.72%
- Debt To Equity
- 3.15x
- Free Cash Flow TTM
- $-522.00K
- Net Revenue TTM Growth 1Y
- -14.90%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CV Sciences, Inc. in?
CV Sciences, Inc. (CVSI) operates in the Pharmaceutical Preparations industry.
What exchange does CVSI trade on?
CV Sciences, Inc. (CVSI) trades on the OTC.
Where is CV Sciences, Inc. incorporated?
CV Sciences, Inc. is incorporated in DE.
When was CV Sciences, Inc. (CVSI)'s most recent SEC filing?
CV Sciences, Inc. (CVSI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CVSI's market cap?
CV Sciences, Inc. (CVSI) has a market capitalization of $4.10M as of 2026-06-30.
What is CVSI's EPS (earnings per share)?
CV Sciences, Inc. (CVSI)'s trailing twelve month EPS is $-0.01 as of 2026-06-30.
What is CVSI's ROE (return on equity)?
CV Sciences, Inc. (CVSI)'s trailing twelve month Return on Equity (ROE) is -118.91% as of 2026-06-30.
What is CVSI's ROA (return on assets)?
CV Sciences, Inc. (CVSI)'s trailing twelve month Return on Assets (ROA) is -27.72% as of 2026-06-30.
What is CVSI's ROIC (return on invested capital)?
CV Sciences, Inc. (CVSI)'s trailing twelve month Return on Invested Capital (ROIC) is -48.14% as of 2026-06-30.
What is CVSI's EV/EBITDA?
CV Sciences, Inc. (CVSI)'s trailing twelve month EV/EBITDA is -4.42x as of 2026-06-30.